The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

NC was one of 18 states with "high" or "very high" levels in wastewater, according to CDC monitoring. Here's what to know ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about ...